Our previous single-cell RNA-seq data from human preimplantation embryos showed that female X-chromosome mRNA levels become partly dose compensated during the timespan between zygotic genome activation (ZGA) and implantation. At the same time, XIST RNA is expressed from, and forms clouds in proximity to, both X-chromosome copies and biallelic expression of other X-linked genes persists. We proposed that X-chromosome transcription is transiently lowered on both alleles before X-chromosome inactivation (XCI) takes place. This notion was recently challenged in a reanalysis performed by Moreira de Mello et al, claiming to provide evidence against biallelic expression dampening and that instead proper XCI was responsible for the observed dosage compensation. Here we have addressed this reanalysis and highlighted methodological issues, and we conclude a current lack of evidence against biallelic X-chromosome dampening.
Introduction
We earlier provided a data resource containing 1,529 single-cell RNA-seq libraries spanning embryonic day (E) 3-7 of the human preimplantation development 1 . Analyzing these data, we uncovered for the first time that RNA levels of X-chromosome expression become partly dose compensated during the human female preimplantation development E4-E7, following the major wave of ZGA occurring E3-E4. Surprisingly, this dosagecompensation event took place even though key features of proper XCI were absent, since X-linked genes were biallelically deteted and XIST RNA was expressed from, and clouded, both Xchromosomes in most female E7 cells, as shown by our single-cell RNA-seq and RNA-FISH data. Interestingly, biallelic clouds of XIST simultaneous with biallelic primary transcript foci for unsilenced X-linked genes were reported also in an earlier RNA-FISH-based study 2 on late human female preimplantation embryos, together with the lack of heterochromatic Barr bodies in female nuclei. Based on the single-cell RNA-seq and RNA-FISH results we proposed that the expression levels from both X chromosomes are transiently reduced in female preimplantation cells, preceding proper XCI through which near complete silencing of a single X chromosome transpires. An alternative, but perhaps more ambiguous, wording to describe this phenomenon would be that partial XCI initiates on both X-copies. We termed the transient biallelic expression reduction "X-chromosome dampening". Transcriptionally dampened biallelic Xchromosome states were soon after reported in naïve human embryonic stem cells 3 , albeit at low cellular frequency under the available in vitro conditions. Intriguingly, Sousa et al recently reported 4 that also mouse female embryonic cells at the onset of differentiation accumulate Xist on both X chromosomes, leading to reduced expression or partial silencing on both alleles before resorting to proper XCI. Some time ago, Moreira de Mello et al published an article 5 in Scientific Reports in which they claimed to have challenged the dampening hypothesis by a reanalysis of our human preimplantation single-cell RNA-seq data 1 in conjunction with a dataset 6 from Yan et al. This proposition was based on two main lines of evidences: (1) They reported a decrease in biallelic detection of X-linked transcripts containing single nucleotide polymorphisms (SNPs) in female cells E3-E7, albeit also a decrease in male cells, and claimed that this was indicative of XCI in females. (2) They reported that a set of X-linked genes, which they had classified as biallelically expressed, did not become dose-compensated during the preimplantation development. Altogether, they claimed that these data indicated proper XCI and refuted biallelic dampening. In this report, we reexamined Moreira de Mello et al's analysis 5 in the context of our single-cell RNA-seq data, and identified problems that raise questions on the validity of their conclusions.
Results

Changed rate of monoallelic or biallelic detection in single-cell RNA-seq libraries is not in itself indicative of XCI
The first argument against X-chromosome dampening provided by Moreira de Mello et al was a decrease in biallelic SNP detections, reported as a significant (p<0.001) negative correlation between rates of biallelic X-gene detection and embryonic time E3-E7 (Moreira de Mello 2017 5 figure 1). Female cells had a Pearson correlation of -0.21 and male cells had a lower rate of biallelic detection and Pearson correlation of -0.25, and this was interpreted as a sign of XCI in females while the ongoing degradation of maternal RNA in males. These patterns are clearly very different from those obtained in our own allelic analyses of the same data. In males, we detected a drastic clearance of biallelic X-chromosome RNAs between E3 and E4 (convergence close to zero at E4) along with the activation of paternally derived genes (Petropoulos 2016 1 figure 1D and S1H). We interpreted this as the completion of the major wave of ZGA and clearance of maternally derived RNA between E3-E4, in line with previous results 6 . In female cells, we detected a steady rate of biallelic Xchromosome expression throughout the preimplantation development, which did not differ markedly from that of autosomal chromosomes (Petropoulos 2016 1 figure 6 ). It is not worthwhile to here discuss what analysis procedure (SNPfiltering, thresholds etc.) might be the more appropriate for the allele-specific analysis of single-cell RNA-seq data, since this issue is complex and involves a high degree of uncertainty given that the human preimplantation embryos were of unknown and variable haplotypes. Instead, we will directly demonstrate why a slight potential decrease in biallelic detection in single-cell RNAseq libraries is in itself not "indicative of XCI", as claimed by Moreira de Mello et al.
It is now well understood that the probability of detecting biallelic expression of a gene in single-cell RNA-seq (including autosomal genes) is directly dependent on the gene's overall expression level in the cell [7] [8] [9] [10] [11] . This can be understood on the one hand by a biological mechanism, as high-expressed genes have a higher probability to produce transcriptional bursts simultaneously from both alleles at any given time-window of sampling than low-expressed genes 12 . Additionally, RNA molecules present in low copy numbers are more prone to technical dropout during the single-cell library preparation and sequencing, which further exaggerates monoallelic observation. This dependence is demonstrated in Fig. 1 , which shows the fraction biallelic and monoallelic detection in single-cell RNA-seq data as a function of average expression level for autosomal genes (data 9 from hybrid [CAST/EiJ × C57BL/6J] mouse cells with well-characterized genomes). If the expression level of a gene, or a collection of genes, is shifted to lower level ( Fig. 1 , green arrow) the rate of monoallelic calls increases ( Fig. 1 , red arrow) and biallelic calls decreases ( Fig. 1 , blue arrow) -even though the genes are biallelically expressed in the cells over time. The premise in the analysis by Moreira de Mello et al was that Xchromosome gene expression levels are lowered between E4-E7 in female human preimplantation embryos 1 , either by biallelic dampening or by ongoing proper XCI. A potential decrease in biallelic X-gene detection during this time-window is thus by itself strictly insufficient to discern between the models. To indicate XCI using single-cell RNA-seq data it would instead be necessary to show a decrease in biallelic detection that is greater than what is expected from the reduction of expression levels alone. This might be approximated from autosomal expression-level distributions, but none of that were accounted for or even raised as a caveat in the analysis by Moreira de Mello et al. Altogether, the allelic expression analyses presented by Moreira de Mello et al are inconclusive and lack the proper controls. A similar issue in the analysis of rates of biallelic expression during the preimplantation development is present in a paper from Vallot et al 13 (Vallot 2017 13 figure 1 ).
Finally, we visited Supplementary Fig. S4 in Moreira de Mello et al and found that 7/22 autosomal chromosomes were reported to have a "significant" change in fraction biallelically called genes among female embryos during the preimplantation development (5 autosomes having positive and 2 having negative correlation; "Dataset #1", Petropoulos data). In the same supplementary figure and for female embryos in the Yan dataset ("Dataset #2") 12/22 autosomal chromosomes had "significant" negative change in fraction biallelically called genes. Because there is no chromosome-wide silencing of autosomes during the preimplantation development, these numbers serve as a measure of the false-positive rate in Moreira de Mello et al's allelic analysis. This suggests a false discovery rate between ~9% (2/22) and ~55% (12/22) for a reported reduction in biallelic expression of a chromosome.
Biallelically called X-chromosome genes are dose compensated
The second argument against X-chromosome dampening provided by Moreira de Mello et al was that genes which they had called as "biallelic" (thereby not subjected to XCI) did not become dose-compensated during the preimplantation development. We requested and obtained the lists of biallelically called genes from Moreira de Mello et al. (Supplementary Table  1 , containing genes called as "biallelic" per embryonic day E3-E7). We then investigated in our single-cell expression data whether these "biallelic" genes tended to become down-regulated in female cells E4-E7 (i.e. following ZGA), which would be in line with dampening. Indeed, we found that this was the case, as reflected by a negative shift in the distribution of Spearman correlations between mean expression levels (Reads Per Kilobase of transcript per Million reads [RPKM]) and embryonic time exclusively for Xlinked genes in females and not in males (p≤0.001, one-sided Wilcoxon test, Fig. 2 ). Note that it is not expected that all X-linked genes in females would have a negative Spearman correlation with embryonic time in this analysis, since many genes are up-or down-regulated as a function of embryonic development independent of any connection to dosage compensation. What we do expect in a scenario of dosage compensation is a negative shift in the distribution of Spearman correlation values, which is what we observed in female cells (Fig. 2) .
We then investigated mean female-to-male relative expression levels for the "biallelic" genes, and in conflict with results of Moreira de Mello et al we again observed the pattern of dosage compensation E4-E7 (p≤1.8x10 -8 , two-sided Wilcoxon test, Fig. 3) . Notably, female-to-male expression ratios have the benefit of being in part normalized for stage-specific gene-expression changes that are unrelated to dosage compensation, under assumption that the overall transcriptional differentiation program is similar in females and males during these stages.
Next, we checked whether the total (summed) expression of the "biallelic" gene set was reduced E4-E7. Moreira de Mello et al compared the total and median expression between different gene sets (genes called "biallelic" in different stages) over different embryonic time-points (Moreira de Mello 2017 5 figure 3B-C). We, however, do not find this analysis sensible for detecting dosage compensation, since: (1) diverse genes are expressed at vastly different levels without any connection or relevance for dosage compensation, and (2) many genes change drastically (some beyond 100-fold 1 ) in expression levels between E4-E7 as result of the developmental program rather than dosage compensation -which has an expected ≤2-fold effect. When comparing small sets of diverse genes, such as the current "biallelic" sets, it is therefore likely that dosage-compensation effects on sum or median expression become obfuscated by the mentioned factors if not accounted for. It is also important to appreciate that a handful of high-expressed genes may completely dominate the expression-level sums if an upper threshold is not imposed to remove outlier genes. Finally, Moreira de Mello et al did report a decreased total expression of "biallelic" genes, but then questioned whether this change was the result of a decreased number or decreased expression levels of "biallelic" genes with time -which we found to be a somewhat puzzling question given that they should know exactly the number of genes they included in each of their plots and calculations (Moreira de Mello 2017 5 figure 3 ). The mentioned issues considered, we calculated the total expression of the fixed set of genes that were biallelically called at E7 over embryonic time (Fig. 4) , reasoning that if these genes were not subjected to XCI at E7 they would also not be subjected to XCI at earlier stages. After the removal of high-expressed outlier genes (genes with expression levels beyond the 90th percentile -which dominated the total expression, Fig. 4A-B) , we observed the signature of dosage compensation E4-E7 also in terms of their total expression output from the X-chromosome (p=2.8x10 -27 , twosided Wilcoxon test, Fig. 4C-D) . As expected, using the Transcripts Per Million reads (TPM) expression measure instead of RPKM provided very similar results (Supplementary Fig. 1) .
Altogether, our reanalyzes showed that biallelically called Xchromosome genes tended to get dose compensated between E4-E7, as reflected by (1) a negative shift in the distribution of Spearman correlations between expression level and embryonic time; (2) decreasing female-to-male expression ratios; and (3) decreasing total expression. It is possible that the divide in results between us 1 and Moreira de Mello et al 5 derive from differences in sequence-read mapping procedures and/or gene-expression-level calculations. Sample selection could be yet another reason, as we noticed that Moreira de Mello et al excluded about a third of all the single-cell libraries available in our resource. We therefore requested and obtained the processed gene-expression-level (TPM) data and lists of included samples from Moreira de Mello et al, and again performed the above described analyses. Interestingly, we found the signatures of dosage compensation in "biallelic" genes also in Moreira de Mello et al's processed data set, including the reduction of female-to-male expression ratios ( Supplementary  Fig. 2 ).
Conclusions
The presence of an initial biallelic X-chromosome dampening during the human female preimplantation development is an interesting and perhaps provoking thesis under some prevailing dogma in the XCI field, and as such needs to get challenged and tested 14 . However, we did not find the claims, nor the analysis, by Moreira de Mello et al 5 convincing. We would like to emphasize that we do not dismiss the possibility of XCI initiating at some point, or in some fraction of cells, during the preimplantation development. Nevertheless, "compelling evidence against X dampening in human preimplantation embryos" as claimed 5 by Moreira de Mello et al is currently lacking. Furthermore, biallelic dampening and XCI should not be considered mutually exclusive phenomena, but rather that biallelic expression reduction may precede proper XCI, as proposed in our original manuscript 1 and recently reported to occur in some degree also in mouse embryonic cells 4 . It is known since long that expression of a translocated Xist gene induces cloud formation and expression reduction or silencing in cis even on autosomal chromosomes 15 . We propose that dual X-chromosome dampening, which correlates with the appearance of biallelic XIST clouds in female cells, should be experimentally tested in human embryos for which the maternal and paternal X-chromosome haplotypes have been characterized. Such studies should preferably aim at the E4-E6 time-window, as the major wave of ZGA completes around E4 and proper XCI is likely to commence at some point around the time of implantation. Further studies on naïve human embryonic stem cells that express XIST from both alleles 3 would also be valuable. If such analyses are performed using single-cell RNA-seq it is vital that the technical and biological stochastic features present in single-cell data are carefully considered.
Methods
Access to data
Calculations of expression levels (RPKMs) are described earlier 1, 16 . Expression-level data are available together with sample annotations at Sourceforge (https://sourceforge.net /projects/dampening-of-biallelic-genes/files/). Expression levels (TPM) calculated by Moreira de Mello et al, sample annotations, and lists of "biallelic" genes ( Supplementary Table 1 ) were requested and obtained from Joana C. Moreira de Mello and Lygia V. Pereira, and are also available at Sourceforge.
Spearman correlations between expression levels and embryonic time
We included biallelically called genes ( Supplementary Table 1 ) with a mean expression level above 1 RPKM or 1 TPM (E4-E7) and calculated and plotted a smoothed kernel density (bandwidth= 0.15). We noted a negative shift in the distribution for female Xlinked genes, and tested whether the median of female X-linked genes was significantly lower than that of female autosomal and male X-linked genes. P-values for differences in medians were calculated using a one-sided Wilcoxon tests. Using an expressionlevel cutoff of 5 RPKM instead of 1 RPKM provided similar results (Supplementary Fig. 3A-D) .
Female-to-male relative expression levels
We included biallelically called genes ( Supplementary Table 1 ) with a mean expression level above 1 RPKM or 1 TPM (stage-wise for genes called "biallelic" per stage, and E3-E7 for fixed sets of biallelic genes) and calculated the gene-wise female/male ratios of mean expression levels. Ratios of finite value were included in the plots. P-values for differences in medians between E4 and E7 were calculated using a two-sided Wilcoxon test. Using an expression-level cutoff of 5 RPKM provided similar results (Supplementary Fig. 3E-F) .
Total expression
We calculated the mean expression level for each biallelically called E7 gene ( Supplementary Table 1 ) and removed genes with mean RPKM or TPM beyond the 90 th percentile of expression levels (Fig. 4A-C) since such genes would otherwise dominate the total expression estimate. The sum of expression levels (RPKM) was then calculated in each cell for the remaining 90% of genes (Fig. 4D) . Difference in summed expression between E4 and E7 for female cell was calculated using a two-sided Wilcoxon test.
Code accessibility
Computational code used in this analysis is available at Sourceforge (https://sourceforge.net/projects/dampening-ofbiallelic-genes/files/). VCX3B  GAGE1  VCX3A  VCX2  ZFX  PRKX  CHM  VCX  GAGE12J  MTRNR2L10  PIR  MID1  MAGT1  MCTS1  ALG13  EIF1AX  SMS  TXLNG  LDOC1  MAGED1  SMC1A  CXorf56  XAGE3  STS  HDHD1  FAM104B  FAM127B  TSPAN6  FAM127A  UBL4A  BEX4  MAGEB2  LAGE3  PGRMC1  PIN4  AIFM1  VGLL1  LAMP2  ATP6AP2  PLS3  FUNDC1  FMR1NB  MPP1  PRPS1  SAT1  TIMM17B  FAM50A  HMGB3  VBP1  RBM3  TIMM8A  NONO  EIF2S3  RPL39  ATP6AP1  RBMX  PDHA1  PGK1  EBP  TMSB4X 
